Activity of high-dose cyclophosphamide in the treatment of childhood malignant gliomas

Medical and Pediatric Oncology

Volumn 30, Issue 2, 1998, Pages 75-80

  McCowage, Geoffrey B ^b   Friedman, Henry S ^b   Moghrabi, Albert ^a   Kerby, Tracy ^b   Ferrell, Lee ^b   Stewart, Elizabeth ^b   Duncan Brown, Margaret ^b   Fuchs, Herbert E ^b   Tien, Robert ^b   McLendon, Roger E ^b   Lisa Meier, P A C ^b   Kurtzberg, Joanne ^b   Ashley, David ^b   Colvin, O Michael ^b   Longee, Darryl C ^b  

^a UNIVERSITY OF MONTREAL   (Canada)

^b DUKE UNIVERSITY   (United States)

Author keywords

Anaplastic astrocytoma; Childhood brain tumor; Cyclophosphamide; Glioblastoma multiforme

Indexed keywords

ANTIBIOTIC AGENT; CYCLOPHOSPHAMIDE; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; ONDANSETRON;

ADOLESCENT; ADULT; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; CANCER RADIOTHERAPY; CANCER SURGERY; CHILD; CHILDHOOD CANCER; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG HYPERSENSITIVITY; DRUG MEGADOSE; DRUG RESPONSE; FEMALE; GLIOBLASTOMA; HUMAN; INFECTION; INTRAVENOUS DRUG ADMINISTRATION; MALE; NAUSEA; NEUTROPENIA; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; THROMBOCYTOPENIA; TUMOR RECURRENCE;

EID: 0030663433     PISSN: 00981532     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1096-911x(199802)30:2<75::aid-mpo1>3.0.co;2-x     Document Type: Article

References (22)

1. Farwell JR, Dohrmann GJ, Flannery JT: Central nervous system tumors in children. Cancer 40:3123-3132, 1977.
2. Bloom HJG: Intracranial tumors: response and resistance to therapeutic endeavours, 1970-1980. Int J Radiat Oncol Biol Phys 8:1083-1113, 1982.
3. Marchese MJ, Chang CH: Malignant astrocytic gliomas in children. Cancer 65:2771-2778, 1990.
4. Duffner PK, Cohen ME, Meyers MH, Heise HW: Survival of children with brain tumors:SEER program 1973-1980. Neurology 36:597, 1986.
5. Bloom HJG, Glees J, Bell J: The treatment and long-term prognosis of children with intracranial tumors: a study of 610 cases, 1950-1981. Int J Radiat Oncol Biol Phys 18:723-745, 1990.
6. Schold SC Jr, Friedman HS, Bigner DD: Therapeutic profile of the human glioma line D-54 MG in athymic mice. Cancer Treat Rep 71:849-850, 1987.
7. Allen JC, Helson L: High-dose cyclophosphamide chemotherapy for recurrent CNS tumors in children. J Neurosurg 55:749-756, 1981.
8. Sposto R, Ertel IJ, Kenkin RDT, et al: The effectiveness of chemotherapy for treatment of high grade astrocytoma in children: results of a randomized trial. J Neurooncol 7:165-177, 1989.
9. Finlay JL: High-dose chemotherapy followed by bone marrow "rescue" for recurrent brain tumors. In Packer RJ, Bleyer WA, Pochedly C (eds); "Pediatric Neuro-Oncology." Paris: Harwood Academic Publishers. 1992, pp. 278-297.
10. Friedman HS, Colvin OM, Kaufmann SH, Ludeman SM, et al: Cyclophosphamide resistance in medulloblastoma. Cancer Res 52:5373-5378, 1992.
11. Frei E, Teicher BA, Wechi CA, et al: Resistance to alkylating agents: Basic studies and therapeutic implications. In "Mechanisms of Drug Resistance in Neoplastic Cells." Academic Press Inc., San Diego, 1988.
12. Lachance DH, Oette D, Schold SC Jr, Brown M, et al: Dose escalation trial of cyclophosphamide with Sargramostim in the treatment of central nervous system (CNS) neoplasms. Med Pediatr Oncol 24:241-247, 1995.
13. Finlay JL, Boyett JM, Yates AJ, Wisoff JH, et al: Randomized phase III trial in childhood high-grade astrocytoma comparing vincrstine, lomustine, and prednisone with the eight-drugs-in-1-day regimen. A Children's Cancer Group Study. J Clin Oncol 13:112-123, 1995.
14. Hill BT: Interactions between antitumor agents and radiation and the expression of resistance. Cancer Treat Rev 18:149-190, 1991.
15. Horowitz ME, Etcubanas E, Christensen ML, et al: Phase II testing of melphalan in children with newly diagnosed rhabdomyosarcoma: A model for anticancer drug development. J Clin Oncol 6:308-314, 1988.
16. Harris MB, Cantor AB, Goorin AM, et al: Treatment of osteosarcoma with ifosfamide: Comparison of response in pediatric patients with recurrent disease versus patients previously untreated: a Pediatric Oncology Group study. Med Pediatr Oncol 24:87-92, 1995.
17. Moghrabi A, Fuchs H, Brown M, Schold SC Jr, Graham M, et al: Cyclophosphamide in combination with sargramostim for treatment of recurrent medulloblastoma. Med Pediatr Oncol 25:190-196, 1995.
18. Ashley DM, Longee D, Tien R, Fuchs H, et al: Treatment of patients with pineoblastoma with high dose cyclophosphamide. Med Pediatr Oncol, in press, 1995.
19. Allen JC, Kim JH, Packer RJ: Neoadjuvant chemotherapy for newly diagnosed germ-cell tumors of the central nervous system. J Neurosurg 67:65-70, 1987.
20. McCowage GB, Tien R, McLendon R, Felsberg G. et al: Successful treatment of childhood pilocytic astrocytomas metastatic to the leptomeninges with high-dose cyclophosphamide. Med Pediatr Oncol, in press, 1995.
21. Duffner PK, Horowitz ME, Krischer JP, Friedman HS, et al: Post-operative chemotherapy and delayed radiation in children less than three years of age with malignant brain tumors. N Engl J Med 328:1725-1731, 1993.
22. Abrahamsen TG, Lange BJ, Packer RJ, et al: A phase I and phase II trial of dose-intensified cyclophosphamide and GM-CSF in pediatric malignant brain tumors. J Pediatr Hematol Oncol 17:134-139, 1995.